Language

News topic

ATC group ATC R03

Current shortage notices for the ATC group ATC R03, structured by product, country and reporting period.

16 notices

← All shortages

Belgium

Budesonide Teva 0.25 mg/ml nebul. susp. amp. 60 x 2 ml

Active ingredient: Budesonide

View notice details →
Czechia

SERETIDE DISKUS 50MCG/500MCG INH PLV DOS 1X60DÁV

Active ingredient: SALMETEROL A FLUTIKASON

View notice details →
Belgium

Montelukast Teva 10 mg (Impexeco) film-coat. tabl. 98

Active ingredient: Montelukast

View notice details →
Belgium

Serevent Evohaler 25 µg/dose press. inhal. susp. press. cont. 120 doses

Active ingredient: Salmeterol

View notice details →
Czechia

ULTIBRO BREEZHALER 85MCG/43MCG INH PLV CPS DUR 30X1+INH

Active ingredient: INDAKATEROL A GLYCOPYRRONIUM-BROMID

View notice details →
Czechia

SERETIDE DISKUS 50MCG/250MCG INH PLV DOS 1X60DÁV

Active ingredient: SALMETEROL A FLUTIKASON

View notice details →
Belgium

Fasenra 30 mg (Orifarm) inj. opl. s.c. voorgev. pen 1 ml

Active ingredient: Benralizumab

View notice details →
Germany

Allergospasmin N

Active ingredient: Natriumcromoglicat (Ph.Eur.); Reproterolhydrochlorid

View notice details →
Belgium

Anoro Ellipta 55 µg - 22 µg inhalatiepdr. (voorverdeeld) inhalator 30 doses

Active ingredient: Umeclidinium; Vilanterol

View notice details →
Belgium

Montelukast KRKA 10 mg filmomh. tabl. 98

Active ingredient: Montelukast

View notice details →
Czechia

SERETIDE DISKUS 50MCG/500MCG INH PLV DOS 3X60DÁV

Active ingredient: SALMETEROL A FLUTIKASON

View notice details →
Denmark

Salamol 100 mikrogram/dosis inhalationsspray, suspension

Active ingredient: Salbutamol (salbutamolsulfat)

View notice details →
Austria

Xolair 150 mg Injektionslösung im Fertigpen

Active ingredient: OMALIZUMAB

View notice details →
Austria

Montelukast Sandoz 4 mg - Kautabletten

Active ingredient: MONTELUKAST NATRIUM

View notice details →